法规动态

FDA、EMA、TGA 及全球法规动态

#ANAGRELIDE ×

2026年8月30日•1 分钟阅读

FDA Approves ANAGRELIDE (ANDA076811)

FDA has approved the generic oral capsule ANAGRELIDE under ANDA076811, covering 0.5 mg and 1 mg strengths, sponsored by Novitum Pharma and manufactured by ANI Pharmaceuticals.